Latest Blood disorders Stories
Cancer Monthly, the only centralized source of cancer treatment results, adds two new cancers to the database. Raleigh, NC (PRWEB) March 08, 2012 Cancer
A team of researchers at Case Western Reserve University School of Medicine has developed the first "theranostic" agent for the treatment of acute lymphoblastic leukemia (ALL).
Yale researchers have discovered how megakaryocytes or giant blood cells that produce wound healing platelets grow 10 or more times bigger than other blood cells and how they may cause a form of leukemia.
Researchers, led by scientists from Johns Hopkins, have found five previously unknown gene mutations believed to be associated with elevated blood platelet counts in African-Americans, findings they say could someday lead to the development of new drugs to help prevent coronary artery disease.
It’s a disease that affects up to 3, 000 people each year and for sufferers of myelofibrosis, bone pain, bruising and fatigue are just some of the symptoms they live with every day. But now a new drug is changing the game.
People with a blood cancer — myelofibrosis — can benefit from a drug called ruxolitinib, according to a randomized, double-blind, placebo-controlled clinical trial that included patients and researchers from the Stanford University School of Medicine.
A drug that relieves the severe symptoms of a life-threatening bone marrow cancer called myelofibrosis also improves the survival of patients with the disease.
- A political dynamiter.
More Images (1 images) »